Literature DB >> 9201805

Nitric oxide synthase inhibition blocks phencyclidine-induced behavioural effects on prepulse inhibition and locomotor activity in the rat.

C Johansson1, D M Jackson, L Svensson.   

Abstract

The ability of the nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME), to block the behavioural effects of the potent psychotomimetic, phencyclidine, was tested in rats using two different behavioural models. L-NAME was found to block both phencyclidine-induced disruption of prepulse inhibition of acoustic startle and phencyclidine-induced stimulation of locomotor activity. A selective action of L-NAME on the effects of phencyclidine was indicated, since L-NAME did not alter the effects of amphetamine, another potent psychotomimetic, in these behavioural models. These observations suggest that a nitric oxide-dependent mechanism may be involved in the effects of phencyclidine in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9201805     DOI: 10.1007/s002130050280

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

1.  Activation of a nitric-oxide-sensitive cAMP pathway with phencyclidine: elevated hippocampal cAMP levels are temporally associated with deficits in prepulse inhibition.

Authors:  Daniel Klamer; Erik Pålsson; Kim Fejgin; Jianhua Zhang; Jörgen A Engel; Lennart Svensson
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

Review 2.  Oxidative stress in schizophrenia: an integrated approach.

Authors:  Byron K Y Bitanihirwe; Tsung-Ung W Woo
Journal:  Neurosci Biobehav Rev       Date:  2010-10-23       Impact factor: 8.989

3.  Blockade of phencyclidine-induced effects by a nitric oxide donor.

Authors:  M Bujas-Bobanovic; D C Bird; H A Robertson; S M Dursun
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

4.  Dopamine and nitric oxide interaction on the modulation of prepulse inhibition of the acoustic startle response in the Wistar rat.

Authors:  C Salum; F S Guimarães; M L Brandão; E A Del Bel
Journal:  Psychopharmacology (Berl)       Date:  2006-01-10       Impact factor: 4.530

5.  Information processing deficits and nitric oxide signalling in the phencyclidine model of schizophrenia.

Authors:  Erik Pålsson; John Lowry; Daniel Klamer
Journal:  Psychopharmacology (Berl)       Date:  2010-08-28       Impact factor: 4.530

6.  A NOS1 variant implicated in cognitive performance influences evoked neural responses during a high density EEG study of early visual perception.

Authors:  Therese O'Donoghue; Derek W Morris; Ciara Fahey; Andreia Da Costa; John J Foxe; Doreen Hoerold; Daniela Tropea; Michael Gill; Aiden Corvin; Gary Donohoe
Journal:  Hum Brain Mapp       Date:  2011-04-21       Impact factor: 5.038

7.  Habituation of acoustic startle is disrupted by psychotomimetic drugs: differential dependence on dopaminergic and nitric oxide modulatory mechanisms.

Authors:  Daniel Klamer; Erik Pålsson; Aron Revesz; Jörgen A Engel; Lennart Svensson
Journal:  Psychopharmacology (Berl)       Date:  2004-06-02       Impact factor: 4.530

8.  Bromocriptine and quinpirole, but not 7-OH-DPAT or SKF 38393, potentiate the inhibitory effect of L-NAME on ethanol-induced locomotor activity in mice.

Authors:  I Tayfun Uzbay; Hakan Kayir
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-21       Impact factor: 3.000

9.  Critical role of nitric oxide in the modulation of prepulse inhibition in Swiss mice.

Authors:  Ana C Issy; João Francisco C Pedrazzi; Bruno H Yoneyama; Elaine A Del-Bel
Journal:  Psychopharmacology (Berl)       Date:  2013-10-08       Impact factor: 4.530

10.  Abnormal social behavior, hyperactivity, impaired remote spatial memory, and increased D1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockout mice.

Authors:  Koichi Tanda; Akinori Nishi; Naoki Matsuo; Kazuo Nakanishi; Nobuyuki Yamasaki; Tohru Sugimoto; Keiko Toyama; Keizo Takao; Tsuyoshi Miyakawa
Journal:  Mol Brain       Date:  2009-06-18       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.